Leptin transport at the blood--cerebrospinal fluid barrier using the perfused sheep choroid plexus model.
Leptin is secreted by adipose tissue and thought to regulate appetite at the central level. Several studies have explored the central nervous system (CNS) entry of this peptide across the blood-brain and blood-cerebrospinal fluid (CSF) barriers in parallel, but this is the first to explore the transport kinetics of leptin across the choroid plexus (blood-CSF barrier) in isolation from the blood-brain barrier (BBB). This is important as the presence of both barriers can lead to ambiguous results from transport studies. The model used was the isolated Ringer perfused sheep choroid plexus. The steady-state extraction of [(125)I]leptin (7.5 pmol l(-1)) at the blood face of the choroid plexus was 21.1+/-5.7%, which was greater than extraction of the extracellular marker, giving a net cellular uptake for [(125)I]leptin (14.0+/-3.7%). In addition, trichloroacetic acid precipitable [(125)I] was detected in newly formed CSF, indicating intact protein transfer across the blood-CSF barrier. Human plasma concentrations of leptin are reported to be 0.5 nM. Experiments using 0.5 nM leptin in the Ringer produced a concentration of leptin in the CSF of 12 pM (similar to that measured in humans). [(125)I]Leptin uptake at the blood-plexus interface using the single-circulation paired tracer dilution technique (uptake in <60 s) indicated the presence of a saturable transport system, which followed Michaelis-Menten-type kinetics (K(m)=16.3+/-1.8 nM, V(max)=41.2+/-1.4 pmol min(-1) g(-1)), and a non-saturable component (K(d)=0.065+/-0.002 ml min(-1) g(-1)). In addition, secretion of new CSF by the choroid plexuses was significantly decreased with leptin present. This study indicates that leptin transport at the blood-CSF barrier is via saturable and non-saturable mechanisms and that the choroid plexus is involved in the regulation of leptin availability to the brain.
Centre for Neuroscience Research at Guy's Campus, King's College London, London SE1, UK. sarah.thomas@kcl.ac.uk
S A
SA
Thomas
J E
JE
Preston
M R
MR
Wilson
C L
CL
Farrell
M B
MB
Segal
D000818:Animals; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology*; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000502:physiology*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000378:metabolism*; D002560:Cerebrovascular Circulation / Q000502:physiology*; D002831:Choroid Plexus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D004435:Eating / Q000502:physiology; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics; D007700:Kinetics; D020738:Leptin / Q000378:metabolism* / Q000493:pharmacokinetics; D023421:Models, Animal; D009765:Obesity / Q000378:metabolism* / Q000503:physiopathology; D010477:Perfusion; D012756:Sheep / Q000378:metabolism
D007457:Iodine Radioisotopes; D020738:Leptin